Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 2/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29116493 | 0.80 | GSK3B (0.36) | ADORA2AADORA1SPHK1ADORA3 | |
| Threonine SCHEMBL28963051 | 0.79 | P2RY1 (0.36) | ADORA2AADORA1KMT2A | |
| SCHEMBL29278769 | 0.74 | SPHK1 (0.32) | MEN1KMT2ASPHK1 | |
| SCHEMBL26090156 | 0.74 | HTR2B (0.35) | ADORA1HTR2BHTR2CADORA3ADRA2B | |
| SCHEMBL29413061 | 0.74 | HTR2B (0.35) | ADORA1HTR2BHTR2CADORA3ADRA2B | |
| SCHEMBL28894183 | 0.74 | ADORA3 (0.54) | ADORA1ADORA3 | |
| SCHEMBL28894185 | 0.74 | ADORA3 (0.54) | ADORA1ADORA3 | |
| SCHEMBL574739 | 0.73 | P2RY1 (0.50) | KMT2A | |
| SCHEMBL28413161 | 0.72 | ADORA2A (0.32) | ADORA2AADORA1 | |
| SCHEMBL29238711 | 0.72 | HTR2B (0.34) | HTR2BHTR2CADORA3ADRA2BHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023141474-A9 | POLY-TAILED AND POLY-CAPPED MRNA AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-10-26 | — | — | WO | claimed |
| CN-119751285-A | Lipid compounds and lipid nanoparticle compositions | 中生复诺健生物科技(上海)有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-116829578-B | Polynucleotides encoding interleukin-12 (IL-12) and compositions and methods related thereto | 苏州艾博生物科技有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119654141-A | Lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-117083291-B | Coronavirus nucleic acid vaccine based on sequences derived from SARS-CoV-2 Delta strain | 苏州艾博生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119451976-A | Mutant fragments of VZV glycoprotein E | 苏州艾博生物科技有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119137160-A | Nucleic acid vaccine for Respiratory Syncytial Virus (RSV) | 苏州艾博生物科技有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-117580587-B | Coronavirus nucleic acid vaccine based on sequences derived from SARS-CoV-2 Omikovia strain | 苏州艾博生物科技有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-118715201-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118697900-A | Method for preparing lipid nanoparticles | 摩登纳特斯有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-117043343-A | Nucleic acid vaccine for mutant coronaviruses | 苏州艾博生物科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-117003658-A | Lipid Nanoparticle Compositions | 苏州艾博生物科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116940685-A | Coronavirus multivalent nucleic acid vaccine based on sequences derived from SARS-CoV-2Beta and Delta strains | 苏州艾博生物科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116829578-A | Polynucleotides encoding interleukin-12 (IL-12) and compositions and methods related thereto | 苏州艾博生物科技有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116782889-A | Enhanced formulation stability and improved lyophilization process | 生物技术欧洲股份公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116670267-A | Tetravalent mRNA vaccine for influenza virus | 苏州艾博生物科技有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-116472275-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-116323627-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-114206827-B | Lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-110520409-A | Compounds and compositions for intracellular delivery of therapeutic agents | MODERNATX INC | 2019-11-29 | — | — | CN | disclosed |